Swedish National Guidelines on Urothelial Carcinoma: 2021 update on non-muscle invasive bladder cancer and upper tract urothelial carcinoma
| العنوان: | Swedish National Guidelines on Urothelial Carcinoma: 2021 update on non-muscle invasive bladder cancer and upper tract urothelial carcinoma |
|---|---|
| المؤلفون: | Liedberg, Fredrik, Kjellstrom, Sofia, Lind, Anna-Karin, Sherif, Amir, Soderkvist, Karin, Falkman, Karin, Thulin, Helena, Aljabery, Firas, Papantonio, Dimitrious, Strock, Viveka, Ofverholm, Elisabeth, Jerlstrom, Tomas, Sandzen, Johan, Verbiene, Ingrida, Ullen, Anders |
| المصدر: | Scandinavian journal of urology. 56(2):137-146 |
| مصطلحات موضوعية: | Urothelial carcinoma, Swedish national guidelines, non-muscle invasive bladder cancer, upper tract urothelial carcinoma |
| الوصف: | Objective: To overview the updated Swedish National Guidelines on Urothelial Carcinoma 2021, with emphasis on non-muscle-invasive bladder cancer (NMIBC) and upper tract urothelial carcinoma (UTUC).Methods: A narrative review of the updated version of the Swedish National Guidelines on Urothelial Carcinoma 2021 and highlighting new treatment recommendations, with comparison to the European Association of Urology (EAU) guidelines and current literature.Results: For NMIBC the new EAU 2021 risk group stratification has been introduced for non-muscle invasive bladder cancer to predict risk of progression and the web-based application has been translated to Swedish (https://nmibc.netTest.). For patients with non-BCG -responsive disease treatment recommendations have been pinpointed, to guide patient counselling in this clinical situation. A new recommendation in the current version of the guidelines is the introduction of four courses of adjuvant platinum-based chemotherapy to patients with advanced disease in the nephroureterectomy specimen (pT2 or higher and/or N+). Patients with papillary urothelial neoplasms with low malignant potential (PUNLMP) can be discharged from follow-up already after 3 years based on a very low subsequent risk of further recurrences.Conclusions: The current version of the Swedish national guidelines introduces a new risk-stratification model and follow-up recommendation for NMIBC and adjuvant chemotherapy after radical surgery for UTUC. |
| وصف الملف: | electronic |
| الوصول الحر: | https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-485874Test https://doi.org/10.1080/21681805.2022.2041086Test https://uu.diva-portal.org/smash/get/diva2:1700069/FULLTEXT01.pdfTest |
| قاعدة البيانات: | SwePub |
| تدمد: | 21681805 21681813 |
|---|---|
| DOI: | 10.1080/21681805.2022.2041086 |